These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 8427011
1. The cytochromes P-450 are not involved in the modulation of the N-methyl-D-aspartate response by sigma ligands in the rat CA3 dorsal hippocampus. Monnet FP, Debonnel G, de Montigny C. Synapse; 1993 Jan; 13(1):30-8. PubMed ID: 8427011 [Abstract] [Full Text] [Related]
2. Effect of short-term and long-term treatments with sigma ligands on the N-methyl-D-aspartate response in the CA3 region of the rat dorsal hippocampus. Bergeron R, de Montigny C, Debonnel G. Br J Pharmacol; 1997 Apr; 120(7):1351-9. PubMed ID: 9105712 [Abstract] [Full Text] [Related]
3. Potentiation by dehydroepiandrosterone of the neuronal response to N-methyl-D-aspartate in the CA3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors. Debonnel G, Bergeron R, de Montigny C. J Endocrinol; 1996 Sep; 150 Suppl():S33-42. PubMed ID: 8943785 [Abstract] [Full Text] [Related]
4. Differential effects of sigma ligands on the N-methyl-D-aspartate response in the CA1 and CA3 regions of the dorsal hippocampus: effect of mossy fiber lesioning. Debonnel G, Bergeron R, Monnet FP, De Montigny C. Neuroscience; 1996 Apr; 71(4):977-87. PubMed ID: 8684626 [Abstract] [Full Text] [Related]
5. In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands. Monnet FP, Debonnel G, de Montigny C. J Pharmacol Exp Ther; 1992 Apr; 261(1):123-30. PubMed ID: 1532832 [Abstract] [Full Text] [Related]
6. The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin. Monnet FP, Debonnel G, Bergeron R, Gronier B, de Montigny C. Br J Pharmacol; 1994 Jun; 112(2):709-15. PubMed ID: 8075892 [Abstract] [Full Text] [Related]
11. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices. Monnet FP, de Costa BR, Bowen WD. Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358 [Abstract] [Full Text] [Related]
12. Modulation by sigma ligands of N-methyl-D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependency. Monnet FP, Blier P, Debonnel G, de Montigny C. Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):32-9. PubMed ID: 1407002 [Abstract] [Full Text] [Related]
13. Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor. Monnet FP, Debonnel G, Fournier A, de Montigny C. J Pharmacol Exp Ther; 1992 Dec; 263(3):1219-25. PubMed ID: 1469630 [Abstract] [Full Text] [Related]
14. Distinct modulatory roles of sigma receptor subtypes on glutamatergic responses in the dorsal hippocampus. Bermack JE, Debonnel G. Synapse; 2005 Jan; 55(1):37-44. PubMed ID: 15499608 [Abstract] [Full Text] [Related]
15. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems. Gronier B, Debonnel G. Eur J Pharmacol; 1999 Mar 05; 368(2-3):183-96. PubMed ID: 10193654 [Abstract] [Full Text] [Related]
19. In vivo modulation of sigma receptor sites by calcitonin gene-related peptide in the mouse and rat hippocampal formation: radioligand binding and electrophysiological studies. Bouchard P, Monnet F, Bergeron R, Roman F, Junien JL, de Montigny C, Debonnel G, Quirion R. Eur J Neurosci; 1995 Sep 01; 7(9):1952-62. PubMed ID: 8528471 [Abstract] [Full Text] [Related]
20. Modification of the N-methyl-D-aspartate response by antidepressant sigma receptor ligands. Bergeron R, Debonnel G, De Montigny C. Eur J Pharmacol; 1993 Aug 24; 240(2-3):319-23. PubMed ID: 8243549 [Abstract] [Full Text] [Related] Page: [Next] [New Search]